Redpoint Investment Management Pty LTD Catalent, Inc. Transaction History

Redpoint Investment Management Pty LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	BUY	$87.2 - $114.05 $267,616 - $350,019	3,069 New	3,069 $329,000
Q1 2022 Apr 13, 2022	SELL	$94.19 - $124.49 $318,456 - $420,900	-3,381 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$100.34 - $115.69 $339,249 - $391,147	3,381 New	3,381 $366,000
Q1 2021 Apr 13, 2021	SELL	$101.51 - $125.27 $297,728 - $367,416	-2,933 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$85.88 - $105.36 $12,194 - $14,961	-142 Reduced 4.62%	2,933 $305,000
Q3 2020 Oct 09, 2020	BUY	$72.74 - $92.5 $223,675 - $284,437	3,075 New	3,075 $263,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.